Eden Research authorised to use flagship biofungicide for home and garden use

Eden Research, the Milton Park, Oxfordshire AIM-quoted company focused on sustainable biopesticides and plastic-free formulation technology for use in global crop protection, animal health and consumer products industries, has received authorisation for its flagship biofungicide, Mevalone® for home garden use in Italy for the control of a number of important plant pathogens affecting the home grower. The diseases include Botrytis cinerea and powdery mildew, destructive fungal pathogens affecting many plant species.

Mevalone, which is marketed as 3LOGY® in Italy, is already approved for agricultural use across a wide range of crops including: wine and table grapes, tomatoes, apple, pears, strawberries, cucumber, and many more.

Approval for 3LOGY has now been granted for domestic use across a number of crops, allowing retailers to sell 3LOGY to gardeners in Italy for home applications. The use of 3LOGY affords farmers and home growers maximum flexibility in their plant and crop protection as it is free from residues and provides them the important benefit of avoiding higher-than-permitted pesticide residue levels as stipulated by the regulatory authorities.

3LOGY is distributed exclusively in Italy by Eden’s distribution partner, Sipcam-Oxon. Based on natural active ingredients, 3LOGY is a useful tool in plant protection programmes and is aligned with the demanding requirements of integrated pest management programmes. Sipcam has extensive experience with 3LOGY and has also supported significant label extensions in Spain and Portugal. This approval will enable Sipcam to expand the market for 3LOGY into homes across Italy.

READ MORE: Oxford’s Eden Research expects revenue to rise by 50 per cent